Overall MAPS gets a fundamental rating of 6 out of 10. We evaluated MAPS against 278 industry peers in the Software industry. MAPS has an excellent financial health rating, but there are some minor concerns on its profitability. MAPS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make MAPS a good candidate for value investing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

MAPS had positive earnings in the past year.
In the past year MAPS had a positive cash flow from operations.
In multiple years MAPS reported negative net income over the last 5 years.
In multiple years MAPS reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of MAPS (4.09%) is better than 70.14% of its industry peers.
With an excellent Return On Equity value of 13.86%, MAPS belongs to the best of the industry, outperforming 80.22% of the companies in the same industry.
The Return On Invested Capital of MAPS (5.47%) is better than 73.02% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.09%
ROE	13.86%
ROIC	5.47%

ROA(3y)-20.01%

ROA(5y)-12.91%

ROE(3y)-301.64%

ROE(5y)-167.98%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MAPS has a better Profit Margin (4.40%) than 62.95% of its industry peers.
In the last couple of years the Profit Margin of MAPS has declined.
With a decent Operating Margin value of 6.21%, MAPS is doing good in the industry, outperforming 69.78% of the companies in the same industry.
MAPS has a better Gross Margin (95.02%) than 99.28% of its industry peers.
In the last couple of years the Gross Margin of MAPS has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	6.21%
PM (TTM)	4.4%
GM	95.02%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-49.04%

PM growth 5YN/A

GM growth 3Y-0.28%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAPS is destroying value.
The number of shares outstanding for MAPS has been increased compared to 1 year ago.
MAPS has more shares outstanding than it did 5 years ago.
MAPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MAPS has an Altman-Z score of 1.59. This is a bad value and indicates that MAPS is not financially healthy and even has some risk of bankruptcy.
MAPS has a Altman-Z score (1.59) which is comparable to the rest of the industry.
There is no outstanding debt for MAPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	1.59

ROIC/WACC0.49

WACC11.1%

2.3 Liquidity

A Current Ratio of 2.54 indicates that MAPS has no problem at all paying its short term obligations.
MAPS's Current ratio of 2.54 is fine compared to the rest of the industry. MAPS outperforms 69.78% of its industry peers.
A Quick Ratio of 2.54 indicates that MAPS has no problem at all paying its short term obligations.
MAPS has a better Quick ratio (2.54) than 70.14% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.54
Quick Ratio	2.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MAPS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 566.67%, which is quite impressive.
MAPS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.09% yearly.
The Revenue has been growing slightly by 0.59% in the past year.
The Revenue has been decreasing by -1.50% on average over the past years.

EPS 1Y (TTM)566.67%

EPS 3Y-55.61%

EPS 5Y-8.09%

EPS Q2Q%0%

Revenue 1Y (TTM)0.59%

Revenue growth 3Y-1.5%

Revenue growth 5YN/A

Sales Q2Q%-9.4%

3.2 Future

Based on estimates for the next years, MAPS will show a very strong growth in Earnings Per Share. The EPS will grow by 35.31% on average per year.
MAPS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.96% yearly.

EPS Next Y118.57%

EPS Next 2Y47.84%

EPS Next 3Y35.31%

EPS Next 5YN/A

Revenue Next Year-5.06%

Revenue Next 2Y-3.35%

Revenue Next 3Y-0.28%

Revenue Next 5Y8.96%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.52, which indicates a rather cheap valuation of MAPS.
Based on the Price/Earnings ratio, MAPS is valued cheaper than 94.24% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.30. MAPS is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 5.05, the valuation of MAPS can be described as very cheap.
MAPS's Price/Forward Earnings ratio is rather cheap when compared to the industry. MAPS is cheaper than 94.60% of the companies in the same industry.
MAPS is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	5.52
Fwd PE	5.05

4.2 Price Multiples

97.84% of the companies in the same industry are more expensive than MAPS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MAPS is valued cheaper than 96.76% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	5.77
EV/EBITDA	2.73

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MAPS's earnings are expected to grow with 35.31% in the coming years. This may justify a more expensive valuation.